Key result
Mutated human MYOT and CRYAB cause a myofibrillar myopathy phenotype in zebrafish embryos.
Why the study?
The mechanisms by which mutated genes cause protein aggregation in myofibrillar myopathies are unknown.
This zebrafish model successfully recapitulates the myopathic phenotype of human myofibrillar myopathy caused by specific MYOT and CRYAB mutations, providing a tool for disease modeling.
Zebrafish MYOT/CRYAB model recapitulates myofibrillar myopathy; extends preclinical tools but leaves open human translation.
Myofibrillar myopathies (MFMs) are a group of hereditary neuromuscular disorders sharing common histological features, such as myofibrillar derangement, Z-disk disintegration, and the accumulation of degradation products into protein aggregates. They are caused by mutations in several genes that encode either structural proteins or molecular chaperones. Nevertheless, the mechanisms by which mutated genes result in protein aggregation are still unknown. To unveil the role of myotilin and αB-crystallin in the pathogenesis of MFM, we injected zebrafish fertilized eggs at the one-cell stage with expression plasmids harboring cDNA sequences of human wildtype or mutated MYOT (p.Ser95Ile) and human wildtype or mutated CRYAB (p.Gly154Ser). We evaluated the effects on fish survival, motor behavior, muscle structure and development. We found that transgenic zebrafish showed morphological defects that were more severe in those overexpressing mutant genes. which developed a myopathic phenotype consistent with that of human myofibrillar myopathy, including the formation of protein aggregates. Results indicate that pathogenic mutations in myotilin and αB-crystallin genes associated with MFM cause a structural and functional impairment of the skeletal muscle in zebrafish, thereby making this non-mammalian organism a powerful model to dissect disease pathogenesis and find possible druggable targets.
No takes yet. Share an insight, caveat, or question.
Cannone et al. (2023) studied Myofibrillar myopathy (MFM). Mutated human MYOT (p.Ser95Ile) and CRYAB (p.Gly154Ser) expression plasmids vs. Non-injected embryos and embryos injected with wildtype human MYOT or CRYAB was evaluated on Myopathic phenotype development (motor behavior, muscle structure, survival). Overexpression of mutated human MYOT S95I and CRYAB G154S in zebrafish embryos caused a myopathic phenotype consistent with human myofibrillar myopathy, including motor impairment and protein aggregates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: